(Q44744832)

5 December 2017

title

Trials of vaccination against experimental autoimmune uveoretinitis with a T-cell receptor peptide (English)

1 reference

5 December 2017

Kawano Y

1

1 reference

5 December 2017

Sasamoto Y

2

1 reference

5 December 2017

Kotake S

3

1 reference

5 December 2017

Thurau SR

4

1 reference

5 December 2017

Wiggert B

5

1 reference

5 December 2017

Gery I

6

1 reference

5 December 2017

language of work or name

1 reference

1 August 1991

1 reference

5 December 2017

1 reference

5 December 2017

volume

10

1 reference

5 December 2017

issue

8

1 reference

5 December 2017

page(s)

789-795

1 reference

Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

Lines of T Lymphocytes Induce or Vaccinate Against Autoimmune Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

Regulation of autoimmune disease physiological and therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

Vaccination against experimental autoimmune encephalomyelitis using a subencephalitogenic dose of autoimmune effector cells (1). Characteristics of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

Structure, function, and serology of the T-cell antigen receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

The V-region disease hypothesis: evidence from autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

Conserved T cell receptor V gene usage by uveitogenic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphotoreceptor retinoid-binding protein (IRBP).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

Acquired resistance to experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713689109013873

10.3109/02713689109013873

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference